Incidence of pancreatitis in HIV-infected patients: Comment on findings in EuroSIDA cohort

AIDS

Volumn 22, Issue 1, 2008, Pages 145-147

  Fessel, Jeffrey ^a,c   Hurley, Leo B ^b  

^a Clinical Trials Unit   (United States)

^b DIVISION OF RESEARCH   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLASE; ANTIRETROVIRUS AGENT; COTRIMOXAZOLE; DIDANOSINE; INTERFERON; METHADONE; PENTAMIDINE; RIBAVIRIN; STAVUDINE; TRIACYLGLYCEROL LIPASE;

ALCOHOL CONSUMPTION; AMYLASE BLOOD LEVEL; COHORT ANALYSIS; COMPARATIVE STUDY; DRUG EFFICACY; DRUG POTENTIATION; EDITORIAL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; PANCREATITIS; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; RISK FACTOR; TRIACYLGLYCEROL LIPASE BLOOD LEVEL;

ANTI-HIV AGENTS; DIDANOSINE; HIV INFECTIONS; HUMANS; INCIDENCE; PANCREATITIS; STAVUDINE;

EID: 37349098732     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAD.0b013e3282f030a9     Document Type: Editorial

References (8)

1. Dutta SK, Ting CD, Lai LL. Study of prevalence, severity, and etiological factors associated with acute pancreatitis in patients infected with human immunodeficiency virus. Am J Gastroenterol 1997; 92:2044-2048.
2. Reisler RB, Murphy RL, Redfield RR, Parker RA. Incidence of pancreatitis in HIV-1-infected individuals enrolled in 20 adult AIDS Clinical Trials Group studies: lessons learned. J Acquir Immune Defic Syndr 2005; 39:159-166.
3. Reisler RB, Han C, Burman WJ, Tedaldi EM, Neaton JD. Grade 4 events are as important as AIDS events in the era of HAART. J Acquir Immune Defic Syndr 2003; 34:379-386.
4. Grasela TH, Walewander CA, Beltangady M, Knupp CA, Martin RR, Dunkle LM, et al. Analysis of risk factors asociated with the development of pancreatitis in phase 1 patients with AIDS or AIDS-related complex receiving didanosine. J Infect Dis 1994; 169:1250-1255.
5. Maxson CJ, Greenfield SM, Turner JL. Acute pancreatitis as a common complication of 2′,3′-dideoxyinosine therapy in the acquired immunodeficiency syndrome. Am J Gastroenterol 1992; 87:708-713.
6. Moore RD, Keruly JC, Chaisson RE. Incidence of pancreatitis in HIV-infected patients on nucleoside RTIs. In: 8th Conference on Retroviruses and Opportunistic Infections. Chicago, IL, 4-8 February 2001. Abstract no. 620.
7. Rainey PM, Friedland G, McKance-Katz EF, Andrews L, Mitchell SM, Charles C, Jatlow P. Interaction of methadone with didanosine and stavudine. J Acquir Immune Defic Syndr 2000; 24:214-248.
8. Hester J, Keiser P, Berggren R, Pancreatitis: an emerging complication of HCV treatment in HIV co-infected patients treated with didanosine/stavudine containing regimens. In: 41st Interscience Conference on Antimicrobial Agents and Chemotherapy. 16-19 December 2001. Abstract no. H-739.